FY26 Begins Strong for Titan's EyeCare, but Q2 Continues to Lag Seasonal Highs

Q2 FY26 Revenue
₹218 Cr
+9% YoY Growth in Q2 FY26
Source: Titan Company Quarterly Filings
Datum www.datumintell.com

About the Company

Titan Eye+, launched in March 2007 by Titan Company (Tata Group), redefined India's prescription eyewear industry with international quality standards, transparent pricing, and contemporary design. Operating 550+ exclusive stores across 229+ cities, it competes in the fragmented ₹30,000 Cr+ Indian optical retail market.

About This Chart

EyeCare shows recovery after soft FY24. Q1 FY26 hit ₹236 Cr (+13% YoY) — strongest Q1 in four years. Q2 moderated to ₹218 Cr (+9% YoY), a recurring seasonal pattern driven by lower discretionary spending and absence of promotional triggers.

₹236 Cr
Q1 FY26 Revenue
Strongest Q1 in 4 years
₹218 Cr
Q2 FY26 Revenue
+9% YoY growth
<5%
Market Share
Significant headroom for growth
13-14%
FY26 Growth Outlook
Company guidance

Key Insights

What the Data Shows

  • Q1 consistently the strongest quarter due to new year purchases
  • Q2-Q3 typically see 5-10% sequential decline
  • Year-on-year growth remains positive across all quarters

What It Means

  • Recovery trajectory intact after soft FY24 performance
  • Seasonal patterns predictable — plan for Q3 festive uptick
  • <5% market share = significant headroom for growth
Management Commentary

"The eyecare industry is growing at 7-8% and Titan is growing ahead of the industry. We have less than 5% market share, so there's a lot of headroom."

— Titan Company, Q2 FY26 Earnings Call
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Data reflects point-in-time estimates from company filings and may not represent current conditions. Always conduct your own research before making investment decisions.
Link copied to clipboard!